The Abramson Cancer Center of the University of Pennsylvania
Last Modified: March 6, 2012
Jun 4, 2010 - A U.S. Preventive Services Task Force recommendation to discontinue prostate-specific antigen screening at age 75 is not supported by many men, and men ages 75 and older show higher-risk disease and poorer survival, according to research published in the May issue of Urology.
Jun 4, 2010
Sep 24, 2010